See other companies on Otta

Cleerly

AI-powered heart disease diagnostics

101-200 employees
  • Healthcare
  • B2B
  • Artificial Intelligence
  • MedTech
101 Greenwich St, New York City, New York, 10006, United States

Company mission

Cleerly's mission is to create digital care pathways to prevent heart attacks.

Insights

Top investors

Few candidates hear
back within 2 weeks

102% employee growth in 12 months

Otta's take

Sam Franklin headshot

Sam Franklin

CEO of Otta

For all the advancements made in modern medicine, it’s remarkable that cardiovascular diseases still cause around 18 million deaths every year. The WHO estimates that these diseases account for, or contribute to, around 30% of deaths each year.

Traditional heart disease evaluation methods, such as a coronary angiogram, can be invasive - a catheter is threaded through the arm or leg to reach the heart, where it injects dye into its arteries so X-ray images can capture how blood flows through the vessels.

Though serious complications from the procedure are rare, they potentially include injury to the artery, an allergic reaction or kidney damage from the dye, as well as heart attack or stroke. This is a problem that Cleerly is trying to solve by measuring this plaque through AI-powered imaging which analyzes non-invasive coronary CT scans.

The company was founded by the respected cardiologist and radiologist James Min in 2017 and spent its early years developing and refining its tech. However, it recently secured major financial backing, which coincides with CTA imaging’s growing status as a priority measure for patients with suspected heart problems. This is set to propel Cleerly into a period of rapid growth as it looks to keep refining its software to attract and keep new customers in the healthcare industry.

Benefits

  • PURPOSE: Cleerly’s purpose is to create a world without heart attacks. With our new paradigm for precision heart care, we will leave big footprints in the sands of time. Help us make that a reality!
  • GROWTH: We prioritize learning and growth. As a rapid growth company, there is always space for new challenges and responsibilities
  • OWNERSHIP: Everyone on the team contributes to our success, so everyone has equity in the company through our employee stock option incentive plan
  • BENEFITS: Cleerly offers a variety of medical, dental, and vision plans, designed to fit you and your family’s needs. Along with stock options and a 401(k) match program that helps you invest in the future, Cleerly also offers company wide holidays, a winter break, as well as a self-managed PTO policy. Additional benefits include, wellness, home office and learning & development stipends and parental leave benefits for new parents

Company values

  • We strive to earn trust
  • We value and seek out differences
  • We obsess over client success
  • Our curiosity sparks change

Funding (last 2 of 5 rounds)

Jul 2022

$223m

SERIES C

Mar 2022

$16.8m

SERIES C

$311.8m

Total funding

This company has top investors

Founders

Former Professor of Radiology and Medicine in Cardiology at Weill Cornell Medical College and the New York-Presbyterian Hospital. Former Director of the Dalio Institute of Cardiovascular Imaging.

Jobs (3)

All locations

Software Engineering

Operations & Strategy